Why is STING Activation Important in Cancer Therapeutics?
Activation of the STING pathway has shown promise in enhancing the efficacy of existing cancer therapies, including checkpoint inhibitors and radiation therapy. When activated, STING can boost the immune system's ability to recognize and attack cancer cells. This has led to the development of STING agonists, which are currently being tested in clinical trials. These agonists aim to potentiate the anti-tumor immune response, thereby improving patient outcomes.
